These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18316552)

  • 1. Enhanced expression of RAD51 associating protein-1 is involved in the growth of intrahepatic cholangiocarcinoma cells.
    Obama K; Satoh S; Hamamoto R; Sakai Y; Nakamura Y; Furukawa Y
    Clin Cancer Res; 2008 Mar; 14(5):1333-9. PubMed ID: 18316552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma.
    Jinawath N; Chamgramol Y; Furukawa Y; Obama K; Tsunoda T; Sripa B; Pairojkul C; Nakamura Y
    Hepatology; 2006 Oct; 44(4):1025-38. PubMed ID: 17006947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma.
    Obama K; Ura K; Li M; Katagiri T; Tsunoda T; Nomura A; Satoh S; Nakamura Y; Furukawa Y
    Hepatology; 2005 Jun; 41(6):1339-48. PubMed ID: 15880566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.
    Nishino R; Honda M; Yamashita T; Takatori H; Minato H; Zen Y; Sasaki M; Takamura H; Horimoto K; Ohta T; Nakanuma Y; Kaneko S
    J Hepatol; 2008 Aug; 49(2):207-16. PubMed ID: 18490072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced RASGEF1A expression is involved in the growth and migration of intrahepatic cholangiocarcinoma.
    Ura K; Obama K; Satoh S; Sakai Y; Nakamura Y; Furukawa Y
    Clin Cancer Res; 2006 Nov; 12(22):6611-6. PubMed ID: 17121879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.
    Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human REG I gene is up-regulated in intrahepatic cholangiocarcinoma and its precursor lesions.
    Harada K; Zen Y; Kanemori Y; Chen TC; Chen MF; Yeh TS; Jan YY; Masuda S; Nimura Y; Takasawa S; Okamoto H; Nakanuma Y
    Hepatology; 2001 May; 33(5):1036-42. PubMed ID: 11343228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of PSF2, a member of the GINS multiprotein complex, in intrahepatic cholangiocarcinoma.
    Obama K; Ura K; Satoh S; Nakamura Y; Furukawa Y
    Oncol Rep; 2005 Sep; 14(3):701-6. PubMed ID: 16077978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
    Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
    J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection.
    Tonouchi A; Ohtsuka M; Ito H; Kimura F; Shimizu H; Kato M; Nimura Y; Iwase K; Hiwasa T; Seki N; Takiguchi M; Miyazaki M
    Am J Gastroenterol; 2006 Jul; 101(7):1601-10. PubMed ID: 16863567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
    Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY
    Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells.
    Guo N; Chen R; Li Z; Liu Y; Cheng D; Zhou Q; Zhou J; Lin Q
    Acta Biochim Biophys Sin (Shanghai); 2011 May; 43(5):354-61. PubMed ID: 21450690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
    Maeda T; Taguchi K; Aishima S; Shimada M; Hintz D; Larusso N; Gores G; Tsuneyoshi M; Sugimachi K; Wands JR; de la Monte SM
    Cancer Detect Prev; 2004; 28(5):313-8. PubMed ID: 15542253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelotype analysis of intrahepatic cholangiocarcinoma.
    Kang YK; Kim YI; Kim WH
    Mod Pathol; 2000 Jun; 13(6):627-31. PubMed ID: 10874666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
    Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
    Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma.
    Min JK; Kim JM; Li S; Lee JW; Yoon H; Ryu CJ; Jeon SH; Lee JH; Kim JY; Yoon HK; Lee YK; Kim BH; Son YS; Choi HS; Lim NK; Kim DG; Hong HJ
    Clin Cancer Res; 2010 Jul; 16(14):3571-80. PubMed ID: 20501614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.
    Kang YK; Kim WH; Lee HW; Lee HK; Kim YI
    Lab Invest; 1999 Apr; 79(4):477-83. PubMed ID: 10212000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.
    Zhang KS; Zhou Q; Wang YF; Liang LJ
    Oncol Rep; 2013 Sep; 30(3):1430-8. PubMed ID: 23799613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.